BE768269A - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
BE768269A
BE768269A BE768269A BE768269A BE768269A BE 768269 A BE768269 A BE 768269A BE 768269 A BE768269 A BE 768269A BE 768269 A BE768269 A BE 768269A BE 768269 A BE768269 A BE 768269A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BE768269A
Other languages
French (fr)
Inventor
P R Sheth
G Katz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE768269A publication Critical patent/BE768269A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE768269A 1970-06-10 1971-06-09 PHARMACEUTICAL COMPOSITION BE768269A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4524470A 1970-06-10 1970-06-10

Publications (1)

Publication Number Publication Date
BE768269A true BE768269A (en) 1971-12-09

Family

ID=21936793

Family Applications (1)

Application Number Title Priority Date Filing Date
BE768269A BE768269A (en) 1970-06-10 1971-06-09 PHARMACEUTICAL COMPOSITION

Country Status (8)

Country Link
US (1) US3632778A (en)
BE (1) BE768269A (en)
DE (1) DE2128461A1 (en)
DK (1) DK126236B (en)
ES (1) ES392066A1 (en)
FR (1) FR2100742B1 (en)
GB (1) GB1296505A (en)
NL (1) NL7107643A (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (en) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh PROCESS FOR THE MANUFACTURING OF POROUS TABLETS
US4017636A (en) * 1973-10-23 1977-04-12 Abbott Laboratories Esters of γ-glutamyl amide of dopamine
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
DE2513940A1 (en) * 1975-03-29 1976-10-14 Merck Patent Gmbh PHARMACEUTICAL PREPARATION
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
DE2551446B2 (en) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg METHOD OF MANUFACTURING SUPPOSITORIES
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
DE2845326C2 (en) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Use of a specific microdisperse, amorphous, porous silica for the production of digoxin-containing tablets with a strongly accelerated release of active ingredient
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS5839618A (en) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd Long-acting laminated tablet
CH652025A5 (en) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmaceutical preparation.
US4736527A (en) * 1982-12-13 1988-04-12 Konishiroku Photo Industry Co., Ltd. Apparatus for the heat treatment of powdery material
ATE60711T1 (en) * 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh PHARMACEUTICALS CONTAINING CLODRONATE AND METHOD OF MANUFACTURE THE SAME.
HU209564B (en) * 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
EA036922B1 (en) * 2014-05-29 2021-01-15 Новартис Аг Ceritinib formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine

Also Published As

Publication number Publication date
FR2100742B1 (en) 1974-09-06
FR2100742A1 (en) 1972-03-24
DK126236B (en) 1973-06-25
US3632778A (en) 1972-01-04
NL7107643A (en) 1971-12-14
DE2128461A1 (en) 1971-12-16
ES392066A1 (en) 1974-10-16
GB1296505A (en) 1972-11-15

Similar Documents

Publication Publication Date Title
BE772190A (en) NEW PHARMACEUTICAL COMPOSITIONS
FI56487B (en) REQUIREMENTS FOR FRAMSTAELLNING AV EN LAETT FLUIDISERBAR INHALERBAR PHARMACEUTICAL COMPOSITION
IS1099B6 (en) New Composition of Substances (Azapurimones)
BE768269A (en) PHARMACEUTICAL COMPOSITION
CH538281A (en) Locked pharmaceutical capsule
BE782981A (en) PHARMACEUTICAL COMPOSITIONS
BE775640A (en) PHARMACEUTICAL COMPOSITION
BE782444A (en) PHARMACEUTICAL COMPOSITIONS
BE760360A (en) COMPOSITION
BE777158A (en) ENCAPSULATED PHARMACEUTICAL COMPOSITIONS
BE776769A (en) PHARMACEUTICAL COMPOSITION
FR2100950A1 (en) PHARMACEUTICAL COMPOSITION
ATA335773A (en) INSECTICIDE MIXTURE
BE764768A (en) PHARMACEUTICAL COMPOSITIONS
CH528207A (en) Pesticide composition
IT943626B (en) PROFOMED SUBSTANCES
CH541284A (en) Pesticide composition
CH537955A (en) Pesticide composition
BE772487A (en) PHARMACEUTICAL COMPOSITIONS
BE745022A (en) PHARMACEUTICAL COMPOSITION
BE770403A (en) PHARMACEUTICAL PREPARATION
RO63329A (en) PESTICIDE COMPOSITION
BE769011A (en) IGNIGUGE COMPOSITION
BE765235A (en) COMPOSITION
BE788113A (en) IODOPHORE-STEROID PHARMACEUTICAL COMPOSITIONS